Document Detail


Prodrugs of 5-aminolevulinic acid for photodynamic therapy.
MedLine Citation:
PMID:  8972644     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The use of 5-aminolevulinic acid (ALA) as a protoporphyrin IX (PpIX) precursor for photodynamic therapy (PDT) became very popular in a short time. However, despite its advantages, ALA also has a drawback; it shows a poor ability to diffuse through biological membranes because of its low lipophilicity. As a consequence, a high dose of ALA must be administered in order to increase PpIX in the afflicted tissue at a level sufficient for PDT. A possible solution to this problem is the use of derivatives of ALA. ALA prodrugs are expected to have better diffusing properties as a result of their enhanced lipophilicity and are converted into the parent ALA after enzymatic hydrolysis. In this report, results are presented of the synthesis of a number of ALA derivatives. The ALA prodrugs were investigated regarding the optimum conditions for cell penetration and PpIX formation in an in vitro cellular test system. It is shown that several prodrugs do indeed enhance the amount of accumulated PpIX considerably as compared to ALA. Finally, the most promising prodrugs were tested in an animal model and showed increased PpIX formation under these conditions as well.
Authors:
J Kloek; Beijersbergen van Henegouwen
Related Documents :
6128204 - Formation of an n-acetylornithine conjugate of 3-phenoxybenzoic acid in the chicken.
3334864 - Fatty acid desaturation in the intestinal mucosa.
7167404 - The enzyme stability of dehydro-enkephalins.
9723214 - Preferential relative porphyrin enrichment in solar keratoses upon topical application ...
2540384 - The rapid decomposition of biological materials by using a microwave acid digestion bomb.
22214994 - First prokaryotic biodiversity assessment using molecular techniques of an acidic river...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Photochemistry and photobiology     Volume:  64     ISSN:  0031-8655     ISO Abbreviation:  Photochem. Photobiol.     Publication Date:  1996 Dec 
Date Detail:
Created Date:  1997-01-22     Completed Date:  1997-01-22     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0376425     Medline TA:  Photochem Photobiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  994-1000     Citation Subset:  IM    
Affiliation:
Department of Medicinal Photochemistry, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands. j.kloek@chem.leidenuniv.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aminolevulinic Acid / therapeutic use*
Animals
Male
Mice
Mice, Inbred BALB C
Photochemotherapy*
Prodrugs / therapeutic use*
Chemical
Reg. No./Substance:
0/Prodrugs; 106-60-5/Aminolevulinic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Solar-simulated ultraviolet irradiation induces selective influx of CD4+ T lymphocytes in normal hum...
Next Document:  Magnetic resonance imaging in the evaluation of cerebrospinal fluid fistulae.